We will have limited operations from 15:00 Tuesday 24 December 2024 (AEDT) until Thursday 2 January 2025. Find out how to contact us during the holiday period.
SUPIROCIN mupirocin (as calcium) 2% w/w cream tube, Glenmark Pharmaceuticals Australia Pty Ltd, CON-1259
Product name
SUPIROCIN mupirocin (as calcium) 2% w/w cream tube
Sponsor name
Glenmark Pharmaceuticals Australia Pty Ltd
Consent start
Consent no.
CON-1259
Duration
The consent is effective from 31 July 2024 until 30 June 2026.
Standard
Paragraph 8(1)(i) of Therapeutic Goods Order No. 91 - Standard for labels of prescription and related medicines
Non-compliance with standard
The products contain the name and contact details of the previous sponsor, Freyr Australia Pty Ltd, rather than the current sponsor, Glenmark Pharmaceuticals Australia Pty Ltd.
Conditions imposed
The agreement in place with the previous sponsor regarding adverse events, product complaints and enquires will remain valid until the expiry of stock in the market.
Import, Supply, &/or Export
import and supply
Therapeutic product type
Prescription medicines